Author: Qu, Changbo; Fuhler, Gwenny M.; Pan, Yihang
Title: Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? Cord-id: 6nkzzu7m Document date: 2021_5_26
ID: 6nkzzu7m
Snippet: COVID-19 has rapidly become a pandemic worldwide, causing extensive and long-term health issues. There is an urgent need to identify therapies that limit SARS-CoV-2 infection and improve the outcome of COVID-19 patients. Unbalanced lung inflammation is a common feature in severe COVID-19 patients; therefore, reducing lung inflammation can undoubtedly benefit the clinical manifestations. Histamine H1 receptor (H1 receptor) antagonists are widely prescribed medications to treat allergic diseases,
Document: COVID-19 has rapidly become a pandemic worldwide, causing extensive and long-term health issues. There is an urgent need to identify therapies that limit SARS-CoV-2 infection and improve the outcome of COVID-19 patients. Unbalanced lung inflammation is a common feature in severe COVID-19 patients; therefore, reducing lung inflammation can undoubtedly benefit the clinical manifestations. Histamine H1 receptor (H1 receptor) antagonists are widely prescribed medications to treat allergic diseases, while recently it has emerged that they show significant promise as anti-SARS-CoV-2 agents. Here, we briefly summarize the novel use of H1 receptor antagonists in combating SARS-CoV-2 infection. We also describe the potential antiviral mechanisms of H1 receptor antagonists on SARS-CoV-2. Finally, the opportunities and challenges of the use of H1 receptor antagonists in managing COVID-19 are discussed.
Search related documents:
Co phrase search for related documents- abdominal adiposity and lung injury: 1
- acidic environment and lung inflammation: 1
- acidic environment and lung injury: 1
- acidic environment and lysosome acidic environment: 1
Co phrase search for related documents, hyperlinks ordered by date